Keywords: priority, review, takeda, actos, usa, food, drug

Priority review for Takeda's Actos in USA

Article | 18 March 1999

The US Food and Drug Administration has granted Takeda' glitazone drugActos (pioglitazone hydrochloride) a priority review for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lilly

Go to company listing

Related Drugs

Actos

Pioglitazone

Rezulin

Avandia

rosiglitazone

Go to drug listing